Open AccessCongenital Mesoblastic Nephroma in a Premature Neonate: Should We Give Adjuvant Chemotherapy?
Author(s) -
Nahla Kechiche,
Dorsaf Makhlouf,
S. Belhassen,
Nahla Hmidi,
Lamiri Rachida,
Mekki Mongi,
Belguith Mohssen,
Abdellatif Nouri
Publication year - 2019
Publication title -
journal of neonatal surgery
Language(s) - English
Resource type - Journals
ISSN - 2226-0439
DOI - 10.47338/jns.v8.242
Subject(s) - medicine , nephrectomy , adjuvant chemotherapy , chemotherapy , surgery , adjuvant therapy , adjuvant , renal tumor , kidney , cancer , breast cancer
Congenital mesoblastic nephroma (CMN) is a rare renal tumor of infancy. Complete surgical excision is often sufficient. A premature neonate underwent left radical nephrectomy for CMN without any adjuvant therapy. Pathology was consistent with cellular type CMN. Six months postoperatively, the patient developed recurrence. He subsequently underwent re-excision without any adjuvant chemotherapy. The baby is tumor free for more than a year.